ROYAL BANK OF CANADA - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 84 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,000
-66.7%
11,578
-59.5%
0.00%
Q4 2022$3,00028,574
+1105.1%
0.00%
Q3 2022$0
-100.0%
2,371
+13.1%
0.00%
Q2 2022$2,000
-86.7%
2,097
-82.4%
0.00%
Q1 2022$15,000
-82.4%
11,922
-72.6%
0.00%
Q4 2021$85,000
+54.5%
43,579
+119.4%
0.00%
Q3 2021$55,000
+34.1%
19,862
+51.2%
0.00%
Q2 2021$41,00013,136
+6468.0%
0.00%
Q1 2020$02000.0%0.00%
Q4 2019$02000.0%0.00%
Q3 2019$02000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders